LAUSR

BACKGROUND Exposure to fine particulate matter (PM2.5) is one of the leading contributors to disease burden. However, little is known about the spatial and temporal trends of the disease burden attributable to PM2.5 in the three major economies in East Asia. We aimed to estimate the patterns and temporal variations of the disease burden attributable to PM2.5 in China, Japan, and South Korea from 1990 to 2017. METHODS We obtained data on disease burden attributable to PM2.5 from the Global Burden of Disease Study (GBD) 2017. We retrieved the numbers and age-standardized mortality rate (ASMR) and disability-adjusted life years (DALYs) rate (ASDR) of disease attributable to PM2.5 by age, sex, socio-demographic index (SDI), and country. We used percentage change and estimated annual percentage change (EAPC) to assess the trends of ASMR and ASDR attributable to PM2.5 between 1990 and 2017. We further calculated the contribution of population growth, population aging, and changes in mortality or DALYs rate to the net changes in total deaths and DALYs associated with PM2.5. RESULTS We found considerable differences in the disease burden attributable to PM2.5 in China, Japan, and South Korea. In 2017, the ASMR and ASDR of disease attributable to PM2.5 in China were 49.37 (95% UI: 41.18, 57.5) per 100,000 population and 1065.9 (95% UI: 891.28, 1237.38) per 100,000 population, respectively, which was about four times higher than that of Japan and twice higher than that of South Korea. Regardless of country, the ASMR and ASDR were more pronounced among elders and males. From 1990 to 2017, the declines in ASMR and ASDR were more pronounced in Japan and South Korea than in China. The changes in PM2.5 associated total deaths and DALYs between 1990 and 2017 were the combined effects of population aging, population growth, and changes in mortality or DALY rate, resulting in a net increase in total deaths and DALYs in China but little changes in Japan and South Korea. CONCLUSIONS PM2.5 still contributed to significant disease burdens in 2017, although age-standardized disease burden has declined from 1990 to 2017. There has been an increasing trend in total deaths and DALYs in China, which was primarily driven by population aging.